Business Standard

Covid-19 vaccine: India begins augmenting its cold chain capacity

While the country already has a huge cold chain set-up, it may not be enough for vaccine delivery

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

According to rough estimates, nearly 3 billion people in developing countries will miss out on the Covid-19 vaccine as they live in locations which lack adequate temperature-controlled storage

Sohini DasT E Narasimhan Mumbai/Chennai
From the lab to the jab, the much awaited Covid-19 vaccine would need continuous sterile refrigeration to remain potent and safe. Hence, both government and private sector players have begun to ramp up capacities in this area.

Experts and industry are divided on their assessment of India’s cold chain capabilities. While some feel that India already has a robust cold chain, thanks to its universal immunisation programme (UIP), others say that existing pharma cold chain capacities may not be adequate. The availability of power in the hinterland is also a concern.

According to rough estimates, nearly 3 billion people in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in